Avian flu’s leap to humans: Understanding risks and prevention strategies

Comprehensive report by the EFSA and ECDC delves into the factors that could prompt an avian influenza virus to evolve and potentially spark a pandemic, emphasizing the One Health approach for effective prevention and risk mitigation strategies.

Arrowhead shelves one cardiometabolic drug candidate, focuses on another

On Tuesday, Arrowhead Pharmaceuticals said it will shift focus to its experimental cardiometabolic drug plozasiran and will deprioritize its work on zodasiran, emphasizing the need

June 26, 2024

Nektar Therapeutics sues Lilly for ‘misconduct’ in drug development deal

A behind-the-scenes feud over a drug development program erupted into public view as Nektar Therapeutics filed a lawsuit accusing Eli Lilly of undermining a project

August 7, 2023

HF-158K1 by HighField Biopharmaceuticals for Prostate Cancer: Likelihood of Approval

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Prostate Cancer.

July 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.